Drug Description in Trials / DrugBank / KEGG DRUG

  

Search results

No. Drug (Description in trials) DrugBank KEGG DRUG KEGG GENES KEGG PATHWAY Disease ID
1Dabigatran[1] Dabigatran (Dabigatran)[1] Dabigatran (Dabigatran) 💬 [1] F2 💬 [8] Complement and coagulation cascades, Coronavirus disease - COVID-19, Neuroactive ligand-receptor interaction, Pathogenic Escherichia coli infection, Pathways in cancer, Phospholipase D signaling pathway, Platelet activation, Regulation of actin cytoskeleton 💬[5] 51, 75, 85, 91, 124 💬
2Dabigatran etexilate[2] Dabigatran (Dabigatran),
Dabigatran etexilate (Teva-dabigatran)		[2] Dabigatran etexilate (Dabigatran etexilate),
Dabigatran (Dabigatran) 💬 		[1] F2 💬 [8] Complement and coagulation cascades, Coronavirus disease - COVID-19, Neuroactive ligand-receptor interaction, Pathogenic Escherichia coli infection, Pathways in cancer, Phospholipase D signaling pathway, Platelet activation, Regulation of actin cytoskeleton 💬[2] 51, 75 💬